NCT07867028

Brief Summary

This study evaluates the collection of dermal interstitial fluid using a vacuum-assisted microneedle device in healthy adult volunteers. The study will assess the device-based collection procedure and characterize the collected dermal interstitial fluid. Healthy adult volunteers will undergo dermal interstitial fluid collection using a vacuum-assisted microneedle device at the Stanford study site. Participants will complete the study procedures described in the protocol, which may include device application, vacuum-assisted microneedle sampling, collection and analysis of dermal interstitial fluid, assessment of procedure-related effects, and follow-up as specified by the study protocol.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P50-P75 for not_applicable healthy

Timeline
48mo left

Started Oct 2026

Longer than P75 for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Oct 2026Sep 2030

First Submitted

Initial submission to the registry

October 1, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

October 1, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 9, 2026

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2028

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2030

Last Updated

October 9, 2026

Status Verified

October 1, 2026

Enrollment Period

1.9 years

First QC Date

October 1, 2026

Last Update Submit

October 6, 2026

Conditions

Keywords

dermal interstitial fluidvacuum-assisted microneedle

Outcome Measures

Primary Outcomes (1)

  • Volume of Dermal Interstitial Fluid Collected

    Volume of dermal interstitial fluid obtained using the vacuum-assisted microneedle device, measured in microliters. Collection performance will be evaluated for the device configuration used during each participant's study visit.

    Baseline

Secondary Outcomes (1)

  • Participant-Reported Pain Associated With Device Use,Reported Ability to Operate the Device With Minimal Assistance and safety

    Baseline and up to 30 days.

Study Arms (1)

Vacuum-Assisted Microneedle Interstitial Fluid Collection

EXPERIMENTAL

Healthy adult volunteers aged 18 years or older will undergo dermal interstitial fluid collection using a vacuum-assisted microneedle device during a single study visit. Each participant will receive one device configuration selected according to the current stage of device development. Collection typically lasts 5 minutes and will not exceed 30 minutes per attempt. With participant permission, collection may be repeated up to twice at different skin sites if the amount collected is insufficient. Participants will receive instructions to report delayed device-related adverse events occurring within 30 days

Device: Vacuum-Assisted Microneedle Device

Interventions

The device comprises an adhesive alignment plate, an applicator containing a microneedle array patch, and a porous dome connected to a pre-evacuated collection tube. The patch is applied to the skin and immediately removed with the applicator. Vacuum then draws dermal interstitial fluid into the dome. Collection typically lasts 5 minutes, with a maximum of 30 minutes per attempt and an expected yield of approximately 15 microliters. Up to two additional collections at different skin sites are permitted with participant permission if the yield is insufficient. Configurations may use different-size collection tubes; flat domes or domes with different curvature radii; and aligned-perforation or triply periodic minimal surface lattice geometries. Each participant receives one configuration.

Vacuum-Assisted Microneedle Interstitial Fluid Collection

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older.
  • Willing to undergo microneedle array patch (MAP) application.

You may not qualify if:

  • History of skin conditions that predispose the participant to adverse reactions to skin puncture. Examples include eczema, psoriasis, and keloids.
  • Active infection, open wound, rash, or skin breakdown on the arm being used for MAP device application.
  • Known allergy to acrylate or device materials.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford University

Stanford, California, 94305, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: This single-site study will enroll 50 healthy adult volunteers to evaluate a vacuum-assisted microneedle device for dermal interstitial fluid collection. Each participant will undergo collection using one device configuration during a single study visit. Configurations will be evaluated sequentially as engineering refinements are developed; configuration assignment will depend on the current stage of development and will not be randomized. With participant permission, collection may be repeated up to twice at different skin sites if the amount collected is insufficient. Participants will receive instructions to report delayed device-related adverse events occurring within 30 days.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor (Research) of Radiology (Diagnostic Sciences Laboratory)

Study Record Dates

First Submitted

October 1, 2026

First Posted

October 9, 2026

Study Start

October 1, 2026

Primary Completion (Estimated)

September 1, 2028

Study Completion (Estimated)

September 1, 2030

Last Updated

October 9, 2026

Record last verified: 2026-10

Data Sharing

IPD Sharing
Will not share

Locations